8th Annual World Bispecific Summit Boston, Massachusetts, USA 26-28 September 2017

Description:
Returning for the 8th time, the World Bispecific Summit is the definitive technical forum uniting industry leaders pioneering progress in this space.

With enormous - and as yet unrealized – potential, it’s crucial that the progress of the bispecific candidates currently in development isn’t hampered by surmountable hurdles. Join
your peers to discuss strategies, select synergistic targets, validate and compare innovative formats, overcome developability challenges and maximize clinical performance.

This year Amgen, Abbvie, MacroGenics, Pfizer and Genentech will be contributing fresh insights, lessons learned and clinical updates specifically geared towards enabling you to realize the potential of your bispecific candidates.

URLs:
Booking: https://go.evvnt.com/130773-1
Brochure: https://go.evvnt.com/130773-2

Price:
Conference Only: Register by June 30: USD 2399,
Conference Only: Register by July 28: USD 2499,
Conference Only: Register by August 25: USD 2599,
Conference Only: Standard Rate: USD 2699

Speakers: Jonathan Davis (Bristol-Myers Squibb), Christoph Spiess (Genentech), Paul Moore (MacroGenics), Dale Ludwig (Eli Lilly), Jonathan Lai (Albert Einstein College of Medicine), Laurence Fayadet-Dilman (Merck), Tariq Ghayur (Abbvie)

Time: 8:00 am to 5:00 pm